CLINICAL_TRIALS
trial_result
· 2013-08-23
Clinical Trial Update: Susceptibility of Motor-Evoked Potentials to Varying Targeted Blood Levels of Dexmedetomidine [Phase 1]
Summary
A Phase 1 study in scoliosis patients evaluating how different targeted blood levels of dexmedetomidine influence motor-evoked potentials.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Children's Hospital Medical Center, Cincinnati | Conditions: Scoliosis | Phase 1 | Status: COMPLETED | Results posted: 2013-08-23